SNOT-22 in a control population

S.E. Erskine, C. Hopkins, A. Clark, S. Anari, N. Kumar, A. Robertson, S. Sunkaraneni, J.A. Wilson, S. Carrie, N. Kara, J. Ray, R. Smith, C. Philpott, C. Philpott, S. Erskine, S. Morris, S. Ahmed, V. Sunkaraneni, P. Jervis, J. PanesaarA. Farboud, R. Cathcart, R. Almeyda, H. Khalil, P. Prinsley, N. Mansell, M. Salam, J. Hobson, J. Woods, E. Coombes

    Research output: Contribution to journalArticlepeer-review

    26 Citations (Scopus)


    To assess SNOT‐22 and its subscales in a non‐rhinosinusitis UK‐wide population.

    Self‐reported questionnaire.

    Based from 30 ENT departments around the UK.

    250 Non‐rhinosinusitis adults – no self‐reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months.

    Main outcome measures
    SNOT‐22, SF‐36.

    The mean SNOT‐22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5 and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains.

    Our data demonstrate differences in SNOT‐22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis.
    Original languageEnglish
    Pages (from-to)81-85
    Number of pages5
    JournalClinical Otolaryngology
    Issue number1
    Early online date5 May 2017
    Publication statusE-pub ahead of print - 5 May 2017


    Dive into the research topics of 'SNOT-22 in a control population'. Together they form a unique fingerprint.

    Cite this